Q3 2023 Holdings
Filed 2023-11-14 | 68 holdings | $2.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $277.8M | 17,503,417 | 13.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $232.4M | 2,003,367 | 11.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $206.0M | 16,944,621 | 9.8% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $89.5M | 1,769,684 | 4.3% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $80.5M | 15,630,327 | 3.8% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $71.2M | 4,163,922 | 3.4% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $58.2M | 1,100,492 | 2.8% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $56.9M | 4,475,384 | 2.7% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $46.4M | 2,678,099 | 2.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $45.0M | 1,635,938 | 2.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $42.4M | 2,574,042 | 2.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $42.3M | 1,102,514 | 2.0% |
| Rayzebio Inc | COM | 75525N107 | $41.2M | 1,857,706 | 2.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $40.9M | 774,200 | 1.9% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $39.8M | 873,966 | 1.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $37.5M | 155,076 | 1.8% |
| Elevance Health Inc(ELV) | COM | 036752103 | $37.2M | 85,378 | 1.8% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $35.9M | 5,661,230 | 1.7% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $35.3M | 1,469,725 | 1.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $33.6M | 4,733,248 | 1.6% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $32.3M | 929,900 | 1.5% |
| Humana Inc(HUM) | COM | 444859102 | $29.1M | 59,851 | 1.4% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $29.0M | 2,404,695 | 1.4% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $27.8M | 13,124,427 | 1.3% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $27.0M | 1,774,252 | 1.3% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $26.0M | 1,868,507 | 1.2% |
| Stryker Corporation(SYK) | COM | 863667101 | $25.9M | 94,738 | 1.2% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $24.8M | 2,971,542 | 1.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $22.8M | 244,391 | 1.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $22.4M | 2,848,827 | 1.1% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $20.3M | 1,284,000 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $20.0M | 2,053,333 | 1.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $15.3M | 3,872,696 | 0.7% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $14.6M | 8,509,126 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $14.3M | 419,568 | 0.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $13.5M | 518,924 | 0.6% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $13.0M | 66,382 | 0.6% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $12.7M | 14,178,045 | 0.6% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $12.7M | 465,282 | 0.6% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $12.6M | 1,324,350 | 0.6% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $11.8M | 761,955 | 0.6% |
| Verve Therapeutics Inc | COM | 92539P101 | $10.7M | 809,777 | 0.5% |
| Absci Corporation(ABSI) | COM | 00091E109 | $10.6M | 8,031,094 | 0.5% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $9.4M | 4,135,061 | 0.4% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $9.3M | 6,280,813 | 0.4% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $9.1M | 5,765,792 | 0.4% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $8.5M | 5,619,914 | 0.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $8.3M | 3,503,190 | 0.4% |
| Science 37 Holdings Inc | COM | 808644108 | $7.9M | 19,808,234 | 0.4% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $7.1M | 427,490 | 0.3% |